Skip to content

How many people have taken the Horvath test? Uncovering the scope of epigenetic age testing

4 min read

Unlike a standardized medical diagnostic, there is no public registry that tracks the total count of how many people have taken the Horvath test. This is because the test is a methodology, not a single commercial product, utilized across numerous academic research studies and licensed for use in various private companies' products.

Quick Summary

No centralized public data exists on the exact number of individuals tested using the Horvath epigenetic clock due to its use across countless academic studies and different private companies.

Key Points

  • No Single Test: There is no singular, publicly tracked test. The 'Horvath test' refers to a scientific methodology and algorithm, not a centralized medical procedure.

  • Vast Research Usage: The methodology has been applied in thousands of academic studies on a combined total of tens of thousands of participants worldwide.

  • Academic vs. Commercial: It has been used in both independent research projects and by private companies offering direct-to-consumer tests, with no public data aggregation.

  • Multiple Clocks: Dr. Horvath has developed several epigenetic clocks (e.g., Pan-Tissue, GrimAge, PhenoAge), each used for different purposes and tested on different populations.

  • Context is Key: Results from commercial tests should be interpreted with caution, as they are not standardized clinical diagnostics but rather wellness indicators.

  • Proprietary Data: Private companies offering tests do not disclose their customer numbers, making a total count impossible to determine.

In This Article

What is the Horvath Test?

The term "Horvath test" refers to one of several epigenetic clock algorithms developed by Dr. Steve Horvath and his colleagues. These clocks measure biological age by analyzing DNA methylation patterns, a process where methyl groups are added to DNA molecules. As a person ages, these methylation patterns change in a predictable way. Horvath's original multi-tissue clock, published in 2013, was a landmark in the field, capable of estimating the chronological age of most human tissues with remarkable accuracy.

Unlike a blood glucose test or a cholesterol panel, the Horvath test is not a single, standardized clinical procedure. Instead, it is a sophisticated bioinformatics tool—an algorithm—that analyzes methylation data collected from biological samples, such as blood, saliva, or tissue. This fundamental distinction is why the question of "how many people have taken it" is not a straightforward one.

The Scope of Academic Research

The most significant application of the Horvath test has been within academic research. Thousands of studies have utilized the Horvath clock and its successors to explore the link between biological age, lifestyle, disease, and mortality. These studies have involved sample sizes ranging from dozens to thousands of participants.

  • Original Research: The initial development of the pan-tissue clock utilized methylation data from over 8,000 samples across 51 different tissues.
  • Large Cohort Studies: Subsequent research has applied the Horvath clock to major, longitudinal cohort studies, which follow large populations over many years. This helps scientists understand how lifestyle factors like diet and exercise correlate with biological aging.
  • Specific Conditions: Researchers have used the clock to study specific health conditions, such as the impact of HIV infection or Down syndrome on epigenetic age acceleration.

Because these studies are conducted independently by different research institutions, with their findings published across hundreds of scientific journals, there is no central database that aggregates the total number of participants. The sum of all these academic samples likely numbers in the tens or even hundreds of thousands over the past decade.

The Rise of Commercial Testing

Beyond academia, several private companies have licensed or developed their own commercial epigenetic age tests based on the groundbreaking work of Horvath and other scientists. These companies market their products directly to consumers who are interested in knowing their own biological age. These tests typically involve sending a blood, saliva, or urine sample to a lab for analysis.

However, the number of customers these companies serve is proprietary business information and is not publicly disclosed. Therefore, while we know a substantial number of consumers have purchased and used these tests, there is no public data to determine the total count. Some examples of companies offering such services include MyDNAge, which licenses a version of Horvath's clock, and Elysium, which uses a related algorithm.

Distinguishing Between Different Horvath Clocks

Another layer of complexity is that "the Horvath test" is not a single entity. Dr. Horvath and his team have developed several generations and types of epigenetic clocks for different applications.

Types of Epigenetic Clocks

  • Pan-Tissue Clock (2013): The original, foundational clock, accurate across a wide range of human tissues.
  • Skin & Blood Clock (2018): A more accurate predictor of chronological age for skin and blood samples.
  • PhenoAge Clock (2018): Designed to predict healthspan and lifespan by correlating with clinical markers like liver fat and glucose levels.
  • GrimAge Clock (2019): A highly predictive clock for future health and lifespan, using DNA methylation to track surrogates for blood proteins and smoking pack-years.

Each of these clocks was developed and validated on a different dataset of samples, and each has been used in countless different studies since its inception. Asking for a single number for all "Horvath tests" is like asking for a single number of all people who have ever taken an academic standardized test.

Comparing Research vs. Commercial Epigenetic Clocks

Feature Academic Research Commercial Testing
Purpose Scientific discovery, understanding the aging process, validating interventions. Personal wellness, providing consumers with a biological age estimate.
Data Sharing Often shared openly with the research community to enable further studies. Proprietary and confidential; results are typically only for the individual.
Transparency Algorithms and methods are published in peer-reviewed journals for scrutiny. Algorithms may be proprietary and not fully disclosed to the public.
Interpretation Results are interpreted by scientists in the context of a larger study, not a personal health directive. Results come with a consumer-facing report, but their actionable health implications are debated.

The Meaning of Your Results

While the commercial availability of epigenetic clocks has made biological age testing accessible, it is crucial for consumers to understand the context of their results. Researchers like Dr. Horvath himself point out the limitations and importance of proper interpretation. A result indicating a "younger" biological age is a positive sign but not a guarantee of a longer life, nor is a "biological age" number a clinical diagnosis. It is best seen as a snapshot of your aging rate relative to your chronological age, influenced by genetics and lifestyle factors.

Conclusion

To answer the question of how many people have taken the Horvath test requires clarification. There is no single, consolidated number. The Horvath test is a suite of analytical algorithms widely used in thousands of academic research projects and licensed to several private companies for consumer use. The collective number of individuals whose data has been analyzed using these methodologies is vast and likely numbers in the tens of thousands, but it is impossible to provide a definitive figure. For a deeper dive into the science of epigenetic clocks, a review of key publications on the topic is a valuable resource. You can find many of these by consulting resources like the National Library of Medicine, via the PMC database.

Frequently Asked Questions

The Horvath test is not a single lab procedure but a suite of algorithms, known as epigenetic clocks, that measure biological age based on DNA methylation levels in a biological sample. It was developed by Dr. Steve Horvath.

A precise count is impossible because the test is a research methodology used by many different academic institutions and licensed to several private companies. There is no central registry tracking all participants or customers.

Yes, variations of the Horvath test and other epigenetic clocks are available to the public through commercial companies that offer direct-to-consumer biological age testing services, such as myDNAge and others.

Researchers use the Horvath test to study various aspects of aging. This includes investigating the effects of lifestyle interventions, disease progression, genetics, and environment on the rate of biological aging in populations.

Chronological age is the number of years since birth. Biological age is a measure of your body's physiological age, reflecting cellular and molecular changes, which the Horvath test estimates using DNA methylation.

Yes, many other epigenetic clocks have been developed, some by Horvath's lab (like GrimAge and PhenoAge) and others by different research groups (like the Hannum clock). They often have different applications and strengths.

Research suggests that some lifestyle factors, such as diet, exercise, and smoking, can influence epigenetic aging rates. One study even found that a specific lifestyle intervention could slow epigenetic aging.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.